Tiziana Life Sciences TLSA
NASDAQ TLSA
$1.01 +0.00 (+0.50%)
As of: Oct 21, 2026 · 2:22 PM EDT

Tiziana Life Sciences (TLSA) Capital Leases (2019 - 2021)

Updated

Tiziana Life Sciences (TLSA) posted Capital Leases of $59,000 for Q2 2021, down 79.9% from $293,040 a year earlier.

Analysis

Tiziana Life Sciences (TLSA) Capital Leases (2019 - 2021) Analysis & Trends

At the end of FY2020, Tiziana Life Sciences' Capital Leases came in at $152,000, up 6.3% from FY2019.

  • In prior years, Tiziana Life Sciences' Capital Leases was $143,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,135.59 Bn 1,104.17 Bn 19.71 Bn
2 Johnson & Johnson 616.92 Bn 535.45 Bn 17.26 Bn
3 AbbVie 501.52 Bn 474.63 Bn 12.70 Bn
4 Merck 367.36 Bn 321.74 Bn 12.21 Bn
5 Novartis Ag 297.93 Bn 261.92 Bn 11.24 Bn
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn
7 Amgen 236.40 Bn 191.80 Bn 7.24 Bn
8 Gilead Sciences 190.72 Bn 164.92 Bn 6.22 Bn
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn
10 Tiziana Life Sciences 120.06 Mn 101.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 59,000.00
Dec 31, 2020 152,000.00
Dec 31, 2019 143,000.00
API Access

Tiziana Life Sciences Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=TLSA&period=max&api_key=YOUR_API_KEY